ATE462423T1 - Ungesättigte arylsulfone zum schutz von normalen zellen gegen die zytotoxische wirkung von chemotherapeutika - Google Patents
Ungesättigte arylsulfone zum schutz von normalen zellen gegen die zytotoxische wirkung von chemotherapeutikaInfo
- Publication number
- ATE462423T1 ATE462423T1 AT00973486T AT00973486T ATE462423T1 AT E462423 T1 ATE462423 T1 AT E462423T1 AT 00973486 T AT00973486 T AT 00973486T AT 00973486 T AT00973486 T AT 00973486T AT E462423 T1 ATE462423 T1 AT E462423T1
- Authority
- AT
- Austria
- Prior art keywords
- normal cells
- chemotherapeutics
- anticancer
- arylsulphones
- unsaturated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/02—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms
- C07C317/10—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/24—Anthracenes; Hydrogenated anthracenes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15912399P | 1999-10-12 | 1999-10-12 | |
PCT/US2000/028250 WO2001026645A1 (en) | 1999-10-12 | 2000-10-11 | Method for protecting normal cells from cytotoxicity of chemotherapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE462423T1 true ATE462423T1 (de) | 2010-04-15 |
Family
ID=22571170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00973486T ATE462423T1 (de) | 1999-10-12 | 2000-10-11 | Ungesättigte arylsulfone zum schutz von normalen zellen gegen die zytotoxische wirkung von chemotherapeutika |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1223923B1 (de) |
JP (1) | JP4780885B2 (de) |
AT (1) | ATE462423T1 (de) |
AU (1) | AU780844B2 (de) |
CA (1) | CA2387539C (de) |
DE (1) | DE60044092D1 (de) |
IL (1) | IL149064A0 (de) |
WO (1) | WO2001026645A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6548553B2 (en) | 1997-10-03 | 2003-04-15 | Temple University-Of The Commonwealth System Of Higher Education | Styryl sulfone anticancer agents |
ATE298234T1 (de) * | 1999-04-02 | 2005-07-15 | Univ Temple | (e)-styrylsulfone als krebsbestreitende mittel |
US6541475B2 (en) * | 2000-04-14 | 2003-04-01 | Temple University - Of The Commonwealth System Of Higher Education | α, β-unsaturated sulfones for treating proliferative disorders |
US6486210B2 (en) * | 2000-04-14 | 2002-11-26 | Temple University—Of the Commonwealth System of Higher Education | Substituted styryl benzylsulfones for treating proliferative disorders |
ATE461915T1 (de) | 2000-10-05 | 2010-04-15 | Univ Temple | Substituierte (e)-styrylbenzylsulfone zur behandlung proliferativer erkrankungen |
CA2439256A1 (en) * | 2001-02-27 | 2002-09-06 | Temple University - Of The Commonwealth System Of Higher Education | (z)-styrylbenzylsulfones and pharmaceutical uses thereof |
US6667346B2 (en) * | 2001-02-28 | 2003-12-23 | Temple University - Of The Commonwealth System Of Higher Education | Method for protecting cells and tissues from ionizing radiation toxicity with α, β unsaturated aryl sulfones |
WO2003072062A2 (en) * | 2002-02-28 | 2003-09-04 | Temple University-Of The Commonwealth System Of Higher Education | Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
US7744889B2 (en) * | 2003-11-14 | 2010-06-29 | Temple University - Of The Commonwealth System Of Higher Education | Alpha, beta-unsaturated sulfoxides for treating proliferative disorders |
NZ565561A (en) * | 2005-07-29 | 2011-01-28 | Onconova Therapeutics Inc | Formulation of radioprotective alpha, beta unsaturated aryl sulfones |
CA2671426C (en) * | 2006-12-13 | 2015-05-26 | Temple University - Of The Commonwealth System Of Higher Education | Sulfide, sulfoxide and sulfone chalcone analogues useful in the treatment of cancer and other proliferative disorders |
EP4001263B1 (de) * | 2019-07-18 | 2024-03-27 | Huaxiashengsheng Pharmaceutical Beijing Co., Ltd. | Carbamatsubstituierte styrylsulfonverbindung, verfahren zu ihrer herstellung und ihre verwendung |
CN111253935B (zh) * | 2019-12-24 | 2022-12-13 | 安徽大学 | 一种双通道检测极性和粘度的双光子荧光探针及其制备方法和用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT93772A (pt) * | 1989-04-17 | 1991-01-08 | Searle & Co | Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer |
EP0439421A1 (de) * | 1990-01-23 | 1991-07-31 | Ciba-Geigy Ag | Mikrobizide Mittel |
AU6112896A (en) * | 1995-06-07 | 1996-12-30 | Sugen, Inc. | Tyrphostin-like compounds for the treatment of cell prolifer ative disorders or cell differentiation disorders |
IL119069A0 (en) * | 1996-08-14 | 1996-11-14 | Mor Research Applic Ltd | Pharmaceutical composition comprising tyrphostins |
DE69828079T2 (de) * | 1997-10-03 | 2005-12-22 | Temple University Of The Commonwealth System Of Higher Education | Styrolsulfone als antikrebsmittel |
-
2000
- 2000-10-11 IL IL14906400A patent/IL149064A0/xx active IP Right Grant
- 2000-10-11 AU AU11989/01A patent/AU780844B2/en not_active Expired
- 2000-10-11 DE DE60044092T patent/DE60044092D1/de not_active Expired - Lifetime
- 2000-10-11 EP EP00973486A patent/EP1223923B1/de not_active Expired - Lifetime
- 2000-10-11 JP JP2001529435A patent/JP4780885B2/ja not_active Expired - Lifetime
- 2000-10-11 WO PCT/US2000/028250 patent/WO2001026645A1/en active IP Right Grant
- 2000-10-11 CA CA2387539A patent/CA2387539C/en not_active Expired - Lifetime
- 2000-10-11 AT AT00973486T patent/ATE462423T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2387539C (en) | 2010-09-21 |
EP1223923A4 (de) | 2007-09-05 |
CA2387539A1 (en) | 2001-04-19 |
JP2003511412A (ja) | 2003-03-25 |
DE60044092D1 (de) | 2010-05-12 |
AU780844B2 (en) | 2005-04-21 |
WO2001026645A1 (en) | 2001-04-19 |
EP1223923B1 (de) | 2010-03-31 |
EP1223923A1 (de) | 2002-07-24 |
JP4780885B2 (ja) | 2011-09-28 |
IL149064A0 (en) | 2002-11-10 |
AU1198901A (en) | 2001-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE462423T1 (de) | Ungesättigte arylsulfone zum schutz von normalen zellen gegen die zytotoxische wirkung von chemotherapeutika | |
ATE406881T1 (de) | Verwendung von alpha, beta ungesättigten arylsulfonen zum schutz von zellen und geweben vor toxizität ionischer strahlung | |
BRPI0607688A2 (pt) | método para inibir a polimerização de tubulina em uma célula; método para tratar ou prevenir um distúrbio proliferativo em um indivìduo; método para bloquear, ocluir ou de outro modo romper o fluxo sangüìneo na neovasculatura; composto; composição farmacêutica e uso do referido método e composto | |
SV2002000586A (es) | Formula de dosificacion de la droga accionada por hidrogel ref. pc11095/700006/b | |
AR012964A1 (es) | Compuetos derivados de bencimidazol, composiciones farmaceuticas que los contienen y su uso en la manufactura de medicamentos para tratar infeccionesvirales | |
UY30819A1 (es) | Derivados de pirazol, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones | |
UY29868A1 (es) | Nucleocidos 4 modificados como agentes antivirales | |
SV2002000248A (es) | Composicion farmaceutica suministrando concentracion aumentada de la droga ref. pc10755ajtj/bb | |
ECSP088913A (es) | Derivados de pirimidina tieno [3,2-d] utiles como inhibidores de fi3q | |
CU23105A3 (es) | DERIVADOS NOVEDOSOS DEL áCIDO AMINODICARBOXILICO CON PROPIEDADES FARMACéUTICAS | |
PA8557001A1 (es) | Nuevos derivados de pirrolidina | |
WO2005044181A3 (en) | Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors | |
UY28736A1 (es) | Derivados de quinazolina | |
BRPI0619732B8 (pt) | distribuidor para uso em um dispositivo de dispensação de medicamento, conjunto de distribuidor e bocal, e, dispositivo de dispensação de medicamento | |
UY30190A1 (es) | Profarmacos mejorados de analogos de cc-1065 | |
CL2008002687A1 (es) | Uso de una combinacion farmaceutica de un compuesto derivado de tieno[3,2-d]pirimidina con un agente quimioterapeutico en el tratamiento de un trastorno hiperproliferativo; kit farmaceutico. | |
CO6362017A2 (es) | Peptidos antivirales terapeuticos | |
AR026560A1 (es) | Recubrimiento | |
CL2007001752A1 (es) | Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral. | |
BRPI0907414A2 (pt) | forma oral de dosagem farmacêutica contendo pelo menos dois medicamentos | |
WO2005065074A3 (en) | Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors | |
HN2003000162A (es) | Derivados de isoindolona, proceso de preparacion y compuestos intermedios de este proceso, su uso como medicamentos, y composiciones farmaceuticas que los contienen. | |
ITRM20030194A1 (it) | Uso di derivati del 7-nitro-2, 1, 3-benzossadiazolo per | |
WO2008006974A3 (fr) | Utilisation de ligands du recepteur h4 de l'histamine pour proteger les progeniteurs hematopoïetiques contre la toxicite hematologique des agents chimiotherapeutiques. | |
DK1140810T3 (da) | Benzensulfonamidderivater samt deres anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |